
Michael H. Davidson, MD, @mdavidsonmd @NewAmsPharma shares groundbreaking results from the ROSE2 Trial on Obacetrapib! Discover a remarkable LDL cholesterol reduction with Obacetrapib + Ezetimibe, paving the way for aggressive LDL-C goals. 🎯👏 [video] buff.ly/3L7O24V
















